.png)
Every day, millions of cells in our bodies die or sustain damage, necessitating their continuous replacement. This ongoing cycle is a part of the body's innate repair mechanism, essential for healing injuries and recovering from illnesses.
Every cell in the body, regardless of its specific role, originates from a unique kind of cell known as a stem cell. During differentiation, a stem cell divides to produce two cells: either another stem cell or a different type of new cell.
Typically, the body possesses sufficient stem cells to meet its requirements for new cell generation. However, certain factors can lead to a deficit in stem cells, impacting the body's ability to heal and combat diseases. The growing interest in cell therapy within the scientific community is fueled by emerging research, suggesting that treatments with various cell types can augment the body's own stem cells, thereby enhancing the regenerative process and promoting healing.
Every cell in the body, irrespective of its role, is derived from stem cells, which possess the ability to differentiate into specialized cells for different organs or tissues as part of a natural growth and development process.
Stem cells function as a key component of the body's innate repair mechanism, replenishing a diverse array of cell types across various structures, organs, and tissues.
Our Hospital-Grade Cord-Blood Stem Cells™ undergo thorough testing to ensure safety and efficacy, including tests for Syphilis, Hep B core Aby, Hep B surface Ag, HIV 1 and 2 plus O, HTLV I/II, Hep C Aby, CMV total Aby, HIV/Hep B/Hep C by NAT, Chagas disease, WNV NAT, and Lyme disease. All stem cells are sourced from an AABB-accredited, FDA-registered lab, adhering to stringent regulations for maximum quality assurance.
.png)
At Cellebration Regenerative Medicine, we exclusively use umbilical cord blood-derived stem cells, chosen for their exceptional quality and effectiveness. Numerous studies confirm these cells deliver remarkable results, making them a top choice in our treatments. This ensures that our therapies not only meet but exceed expectations in terms of safety and efficacy, providing our patients with the best possible outcomes.
Hospital-Grade Cord-Blood Stem Cells™ are younger compared to adult stem cells, and they have longer telomeres. Telomeres are the protective caps on the ends of chromosomes that shorten as cells age. Longer telomeres in cord blood stem cells indicate a greater capacity for cell division and regeneration, which is crucial for effective cell therapy.
Hospital-Grade Cord-Blood Stem Cells™ are multipotent, allowing them to differentiate into various cell types. This versatility is highly beneficial for diverse therapeutic areas such as orthopedics, liver conditions, and cosmetic and anti-aging treatments. Their ability to regenerate tissue makes them especially valuable in managing degenerative bone and joint conditions, supporting liver health, and enhancing skin rejuvenation efforts, providing a foundation for innovative medical solutions in these fields.
One significant benefit of utilizing Hospital-Grade Cord-Blood Stem Cells™ is their natural compatibility with human biology. Developed from the umbilical cord blood of newborns, these cells are less likely to be rejected by the recipient's immune system compared to manufactured or lab-grown cells. This reduced risk of immune rejection minimizes the potential for graft-versus-host disease (GVHD) and other adverse immune responses, enhancing the safety and effectiveness of treatments.
Developing Hospital-Grade Cord-Blood Stem Cells™ is non-invasive and completely safe for the newborn donor, sidestepping the ethical concerns often linked to other sources of stem cells. This contrasts with the ethical issues associated with embryonic stem cell research. Additionally, cord blood allows for the storage of stem cells, providing a readily accessible source for future therapeutic applications.
Hospital-Grade Cord-Blood Stem Cells™ present several advantages over manufactured cells, including natural compatibility with human biology, therapeutic versatility, lower risks of rejection and contamination, ethical acceptability, and potential for personalized medicine. These benefits make them a valuable resource in regenerative medicine and cell-based therapies.
.png)
Commonly, our patient treatment protocols include a minimum of one intravenous (IV) infusion. This simple procedure introduces cells directly into the bloodstream, allowing them to circulate and reach various parts of the body effectively.
In cases of targeted therapy, our protocols frequently employ direct injections into specific regions. Where required, our medical experts use sophisticated imaging methods, such as X-ray fluoroscopy, to precisely administer cells to the intended areas.
.svg)
.svg)
.svg)